Get all premium features to the best stock analysis tool

FARMINGTON, Conn.--(BUSINESS WIRE)--Horizon Technology Finance Corporation (NASDAQ: HRZN) (“Horizon”) (the “Company”), an affiliate of Monroe Capital, today announced it has provided a $40 million loan facility to Hyperfine, Inc. (NASDAQ: HYPR) (“Hyperfine”), with an initial funding of $15 million at closing, and up to $25 million available to support future commercial growth. Hyperfine is a publicly traded health technology company that has developed and is commercializing the Swoop® System, t.

Hyperfine, Inc. (HYPR) Q4 2025 Earnings Call Transcript

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced fourth quarter and full year 2025 financial results and provided a business update. “The launch of our second-generation Swoop® scanner, our Optive AI™ software, and the addition of a new market in the neurology office setting in.

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced that it will report financial results for the fourth quarter and full year 2025 on Wednesday, March 18, 2026. Management will host a corresponding conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. A live audio webcast and an archiv.

GUILFORD, Conn.--(BUSINESS WIRE)--Strong evidence supports the use of AI-powered portable MRI for stroke detection in multiple clinical settings, including the emergency department.

GUILFORD, Conn.--(BUSINESS WIRE)--Results from the NEURO PMR study, presented by Dr. Laszlo Mechtler at the ASN Annual Meeting in San Juan, Puerto Rico, on January 16, 2026.

GUILFORD, Conn.--(BUSINESS WIRE)--Prospective study is designed to evaluate the feasibility and visualization benefits of contrast-enhanced ultra-low-field portable MRI.